论文信息 - Labeling strategies of selected subtypes of the hexahydronaphth[2,3-b]-1,4-oxazine- and octahydrobenzo[g]quinoline-type† - 字舞流文

Labeling strategies of selected subtypes of the hexahydronaphth[2,3-b]-1,4-oxazine- and octahydrobenzo[g]quinoline-type†

T. Moenius | H. Andres | Rhys Salter | T. Ray | J. Nozulak | P. Burtscher | R. Voges | Christoph Züger | Peter Schnelli

[1] L. Vecchia,et al. A New Practical Route for the Manufacture of (4aR,10aR)-9-Methoxy-1-methyl-6-trimethylsilanyl- 1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline , 2003 .

[2] P. Williams,et al. Preparation and Use of Tritiated Schwartz' Reagent (ZrCp2Cl3H) , 1994 .

[3] R. Boer,et al. The adrenoceptor agonist, SDZ NVI 085, discriminates between α1A- and α1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat , 1992 .

[4] M. Walkinshaw,et al. Centrally acting alpha 1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolines. , 1992, Journal of medicinal chemistry.

[5] B. Ganem,et al. Reductive deoxygenation using hydridozirconium enolates: A new synthesis of α,β-unsaturated esters , 1992 .

[6] C. Guilleminault,et al. Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. , 1991, European journal of pharmacology.